Literature DB >> 31966730

Changes of Th1/Th2 cytokines in patients with primary hepatocellular carcinoma after ultrasound-guided ablation.

Lili Ji1, Jun Gu2, Lei Chen3, Dongliu Miao3.   

Abstract

Liver cancer is a malignancy of the digestive system and has a high morbidity and mortality rate. Local intervention has become a viable option in identifying liver treatment. The aim of the present study was to analyze the changes of Th1/Th2 cytokines in patients with primary hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA) treatment. 26 patients with stage III-IV liver cancers and 25 healthy controls were selected to participate in the study. HCC patients were initiated with RFA treatment and the serum levels of alpha fetoprotein (AFP) and Th1/Th2 cytokines were valued. We found that with the level of AFP decreased, the levels of Th1 cytokines including interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) were significantly increased after treatment with RFA (P<0.05). Meanwhile, the levels of Th2 cytokines consist of interleukin-4 (IL-4), IL-6 and IL-10 were decreased markedly on the contrary, and the differences were statistically significant (P<0.05). In conclusion, the levels of Th1/Th2 cytokines were correlated with the change of AFP in patients of HCC after treatment with RFA, which might be an important guiding significance for the prognosis of HCC. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Radiofrequency ablation; Th1/Th2 cytokines; alpha fetoprotein; hepatocellular carcinoma; immunity

Year:  2017        PMID: 31966730      PMCID: PMC6965388     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  4 in total

1.  Study on Changes in Immune Function After Microwave Ablation of Papillary Thyroid Microcarcinoma.

Authors:  Ting Wu; Guo-Qing Sui; Deng-Ke Teng; Qiang Luo; Hui Wang; Yuan-Qiang Lin
Journal:  Cancer Manag Res       Date:  2022-09-21       Impact factor: 3.602

2.  Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma.

Authors:  Peiyan Liu; Qi Zhou; Jia Li
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Hui Liu; Mei Yang; Zhiwei Dong
Journal:  Int J Gen Med       Date:  2022-04-13

Review 4.  Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Kumar Jayant; Nagy Habib; Kai W Huang; Jane Warwick; Ramesh Arasaradnam
Journal:  Diagnostics (Basel)       Date:  2020-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.